Welcome! You are visiting the MyeloRx web site.

Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
Lead Compounds - MRx102
 
A lipophilic prodrug of a natural product
 
Intellectual property exclusively licensed to MyeloRx
 
Manufactured via a three step synthesis from a natural product